The importance of extracellular matrix protein 1 as basement membrane protein in maintaining skin function

Textbook of Aging Skin

Volumn , Issue , 2010, Pages 77-91

  Sercu, Sandy ^a   Oyama, Noritaka ^b   Merregaert, Joseph ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78549264605     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-89656-2_8     Document Type: Chapter

References (40)

1. Mathieu E, Meheus L, Raymackers J, et al. Characterization of the osteogenic stromal cell line MN7: Identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J Bone Miner Res. 1994;9:903-913.
2. Bhalerao J, Tylzanowski P, Filie JD, et al. Molecular cloning, characterization, and genetic mapping of the cDNA coding for a novel secretory protein of mouse. Demonstration of alternative splicing in skin and cartilage. J Biol Chem. 1995;270:16385-16394.
3. Smits P, Bhalerao J, Merregaert J. Molecular cloning and characterization of the mouse Ecm1 gene and its 5' regulatory sequences. Gene. 1999;226:253-261.
4. Smits P, Ni J, Feng P, et al. The human extracellular matrix gene 1 (ECM1): Genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Genomics. 1997;45:487-495.
5. Johnson MR, Wilkin DJ, Vos HL, et al. Characterization of the human extracellular matrix protein 1 gene on chromosome 1q21. Matrix Biol. 1997;16:289-292.
6. Smits P, Poumay Y, Karperien M, et al. Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. J Invest Dermatol. 2000;114: 718-724.
7. Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet. 2003;362:118-123.
8. Sander CS, Sercu S, Ziemer M, et al. Expression of extracellular matrix protein 1 (ECM1) in human skin is decreased by age and increased upon ultraviolet exposure. Br J Dermatol. 2006;154: 218-224.
9. Mongiat M, Fu J, Oldershaw R, et al. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem. 2003;278: 17491-17499.
10. Horev L, Potikha T, Ayalon S, et al. A novel splice-site mutation in ECM-1 gene in a consanguineous family with lipoid proteinosis. Exp Dermatol. 2005;14:891-897.
11. Sercu S, Lambeir AM, Steenackers, et al. ECM1 interacts with fibuline-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain. Matrix Biol. 2009;28:160-169.
12. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan Med Bull. 1990;37:57-84.
13. Hamada T, McLean WH, Ramsay M, et al. Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet. 2002;11:833-840.
14. Urbach EWC. Lipoidosis cutis et mucosae. Virchows Arch Pathol Anat. 1929;273:285-319.
15. Chan I, Liu L, Hamada, et al. The molecular basis of lipoid proteinosis: Mutations in extracellular matrix protein 1. Exp Dermatol. 2007;16(11):881-890.
16. Deckers M, Smits P, Karperien M, et al. Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone. 2001;28:14-20.
17. Han Z, Ni J, Smits P, et al. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J. 2001;15:988-994.
18. French MM, Gomes RR, Jr., Timpl R, et al. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res. 2002;17:48-55.
19. rikawa-Hirasawa E, Wilcox WR, Le AH, et al. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat Genet. 2001;27:431-434.
20. Fujimoto N, Terlizzi J, Aho S, et al. Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions. Exp Dermatol. 2006; 15:300-307.
21. Fujimoto N, Terlizzi J, Brittingham R, et al. Extracellular matrix protein 1 interacts with the domain III of fibulin-1C and 1D variants through its central tandem repeat 2. Biochem Biophys Res Commun. 2005;333:1327-1333.
22. Sercu S, Zhang L, Meregaert J. The extracellular matrix protein 1: Its molecular interaction and implication in tumor progression. Cancer Invest. 2008;26(4):375-384.
23. Mirancea N, Hausser I, Beck R, Metze D, Fusenig NE, Breitkreutz D. Vascular anomalies in lipoid proteinosis (hyalinosis cutis et mucosae): Basement membrane components and ultrastructure. J Dermatol Sci. 2006;42:231-239.
24. Sercu S, Zhang M, Oyama N, et al. Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. J Invest Dermatol. 2008;128 (6):1397-1409.
25. Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res. 2006;66:2621-2629.
26. Pulkkinen L, Uitto J. Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol. 1999;18:29-42.
27. Bekou V, Thoma-Uszynski S, Wendler O, Uter W, Schwietzke S, Hunziker T, Zouboulis CC, Schuler G, Sorokin L, Hertl M. Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA. J Invest Dermatol. 2005; 124:732-740.
28. McMillan JR, Akiyama M, Shimizu H. Epidermal basement membrane zone components: Ultrastructural distribution and molecular interactions. J Dermatol Sci. 2003;31:169-177.
29. McKee KK, Harrison D, Capizzi S, Yurchenco PD. Role of laminin terminal globular domains in basement membrane assembly. J Biol Chem. 2007;282:21437-21447.
30. Sercu S, Poumay Y, Herphelin F, Liekens J, Beek L, Zwijsen A, et al. Functional redundancy of extracellular matrix protein 1 in epidermal differentiation. Br J Dermatol. 2007;157(4):771-775.
31. Uematsu R, Furukawa J, Nakagawa H, Shinohara Y, Deguchi K, Monde K, et al. High throughput quantitative glycomics and glycoform-focused proteomics of murine dermis and epidermis. Mol Cell Proteomics. 2005;4:1977-1989.
32. Oyama N, Chan I, Neill SM, et al. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest. 2004;113:1550-1559.
33. Werner S, Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol. 2001;11:143-146.
34. Boxman IL, Ruwhof C, Boerman OC, Lowik CW, Ponec M. Role of fibroblasts in the regulation of proinflammatory interleukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1. Arch Dermatol Res. 1996;288:391-398.
35. Van Hougenhouck-TullekenW, Chan I, Hamada T, et al. Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa. Br J Dermatol. 2004;151:413-423.
36. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R, Matthews S, Nakura J, Miki T, Ouais S, Martin GM, Mulligan J, Schellenberg GD. Positional cloning of the Werner's syndrome gene. Science. 1996;12(272):258-262.
37. Kitao S, Shimamoto A, Goto M, Miller RW, Smithson WA, Lindor NM, Furuichi Y. Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat Genet. 1999;22:82-84.
38. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990;248:1224-1227.
39. Sercu S, Oyama N, Merregaert J. Importance of extracellular matrix protein 1 (ECM1) in maintaining the functional integrity of the human skin. Open Dermatol J. 2008;2:98-105.
40. Chan I. The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol. 2004;29:52-56.